Found 6 matching trials
Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants
PHASE3Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Pa...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
PHASE3Transthyretin amyloidosis (ATTR) is a disease where the normally occurring ...
Location
University of California, San Diego (UCSD) - Medical Center
A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM
PHASE3This prospective study is designed to evaluate the efficacy, safety, and to...
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
PHASE3Phase 3 efficacy and safety study to evaluate acoramidis (AG10) HCl 800 mg ...
Location
Cedars-Sinai Medical Center
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
PHASE3The AG10-504 study is an open-label extension study of acoramidis in partic...
Location
Multiple Locations
Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult Participants
PHASE1The purpose of this study is to determine the effect of a high-fat, high-ca...